MX2021011059A - Particulas tipo norovirus con estabilidad mejorada. - Google Patents
Particulas tipo norovirus con estabilidad mejorada.Info
- Publication number
- MX2021011059A MX2021011059A MX2021011059A MX2021011059A MX2021011059A MX 2021011059 A MX2021011059 A MX 2021011059A MX 2021011059 A MX2021011059 A MX 2021011059A MX 2021011059 A MX2021011059 A MX 2021011059A MX 2021011059 A MX2021011059 A MX 2021011059A
- Authority
- MX
- Mexico
- Prior art keywords
- ala
- norovirus
- particles
- improved stability
- leu
- Prior art date
Links
- 239000002245 particle Substances 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 abstract 1
- 241000532183 Norovirus GI Species 0.000 abstract 1
- JPPXDMBGXJBTIB-ULQDDVLXSA-N Val-His-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N JPPXDMBGXJBTIB-ULQDDVLXSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19162266 | 2019-03-12 | ||
| PCT/EP2020/056461 WO2020182860A1 (en) | 2019-03-12 | 2020-03-11 | Norovirus-like particles with improved stability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021011059A true MX2021011059A (es) | 2021-10-13 |
Family
ID=65818179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021011059A MX2021011059A (es) | 2019-03-12 | 2020-03-11 | Particulas tipo norovirus con estabilidad mejorada. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220152186A1 (https=) |
| EP (1) | EP3938378B1 (https=) |
| JP (2) | JP7536031B2 (https=) |
| KR (1) | KR20220021451A (https=) |
| CN (1) | CN113557240B (https=) |
| AU (1) | AU2020235344B2 (https=) |
| ES (1) | ES2953232T3 (https=) |
| IL (1) | IL285914B2 (https=) |
| MX (1) | MX2021011059A (https=) |
| WO (1) | WO2020182860A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021011059A (es) * | 2019-03-12 | 2021-10-13 | Icon Genetics Gmbh | Particulas tipo norovirus con estabilidad mejorada. |
| CN114685620A (zh) * | 2020-12-30 | 2022-07-01 | 远大赛威信生命科学(南京)有限公司 | 诺如病毒病毒样颗粒及其用途 |
| US20250002539A1 (en) * | 2021-07-26 | 2025-01-02 | The University Of North Carolina At Chapel Hill | Methods and compositions for norovirus chimeric therapeutics |
| CN118252924A (zh) * | 2022-12-27 | 2024-06-28 | 远大赛威信生命科学(南京)有限公司 | 用于诱发哺乳动物针对诺如病毒的免疫反应的药物组合物及其制备方法和用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU731330B2 (en) | 1997-10-24 | 2001-03-29 | E.I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| HUP0104697A3 (en) | 1998-09-23 | 2003-12-29 | Du Pont | Binary viral expression system in plants |
| DE10109354A1 (de) | 2001-02-27 | 2002-09-05 | Icon Genetics Ag | Rekombinante virale Schaltersysteme |
| DE10121283B4 (de) | 2001-04-30 | 2011-08-11 | Icon Genetics GmbH, 80333 | Verfahren und Vektoren zur Amplifikation oder Expression von gewünschten Nucleinsäuresequenzen in Pflanzen |
| CN1533438A (zh) | 2001-06-08 | 2004-09-29 | �����Ŵ��Ƽ���˾ | 在植物生产蛋白质的方法 |
| MXPA04010410A (es) | 2002-04-30 | 2005-07-05 | Icon Genetics Ag | Vectores de amplificacion basados en trans-empalme. |
| WO2006012906A1 (en) | 2003-11-10 | 2006-02-09 | Icon Genetics Ag | Rna virus-derived plant expression system |
| EP1682667B1 (en) | 2003-11-10 | 2010-05-26 | Icon Genetics GmbH | Rna virus-derived plant expression system |
| EP1564295A1 (en) | 2004-01-23 | 2005-08-17 | Icon Genetics AG | RNA virus-derived plant expression system |
| EP1616959A1 (en) | 2004-07-07 | 2006-01-18 | Icon Genetics AG | Biological safe transient protein expression in plants |
| AU2007267359B2 (en) | 2006-05-29 | 2013-03-14 | Icon Genetics Gmbh | Plant virus-based inducible expression system |
| EP1897953A1 (en) | 2006-09-06 | 2008-03-12 | Icon Genetics GmbH | Potexvirus-derived replicon |
| EP2066354B1 (en) | 2006-09-29 | 2013-04-17 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| JP5846908B2 (ja) | 2009-05-28 | 2016-01-20 | 東洋紡株式会社 | 特性の改変されたグルコースデヒドロゲナーゼ |
| AU2011276328C1 (en) * | 2010-07-06 | 2016-01-21 | Novartis Ag | Norovirus derived immunogenic compositions and methods |
| EP2418283A1 (en) | 2010-08-07 | 2012-02-15 | Nomad Bioscience GmbH | Process of transfecting plants |
| EP2647715A1 (en) | 2012-04-03 | 2013-10-09 | Nomad Bioscience GmbH | Agrobacterium for transient transfection of whole plants |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| CA2913068C (en) | 2013-05-23 | 2023-01-10 | Nomad Bioscience Gmbh | Process of providing plants with abiotic stress resistance |
| EP3375873B1 (en) | 2015-10-22 | 2025-07-02 | Protenova Co., Ltd. | Immunoglobulin-binding polypeptide |
| CA3056812C (en) * | 2017-03-23 | 2022-11-29 | Medicago Inc. | Norovirus fusion proteins and vlps comprising norovirus fusion proteins |
| MX2021011059A (es) * | 2019-03-12 | 2021-10-13 | Icon Genetics Gmbh | Particulas tipo norovirus con estabilidad mejorada. |
-
2020
- 2020-03-11 MX MX2021011059A patent/MX2021011059A/es unknown
- 2020-03-11 EP EP20708137.3A patent/EP3938378B1/en active Active
- 2020-03-11 JP JP2021552611A patent/JP7536031B2/ja active Active
- 2020-03-11 CN CN202080020212.XA patent/CN113557240B/zh active Active
- 2020-03-11 IL IL285914A patent/IL285914B2/en unknown
- 2020-03-11 US US17/438,047 patent/US20220152186A1/en active Pending
- 2020-03-11 KR KR1020217032648A patent/KR20220021451A/ko not_active Ceased
- 2020-03-11 AU AU2020235344A patent/AU2020235344B2/en active Active
- 2020-03-11 WO PCT/EP2020/056461 patent/WO2020182860A1/en not_active Ceased
- 2020-03-11 ES ES20708137T patent/ES2953232T3/es active Active
-
2023
- 2023-09-13 JP JP2023148763A patent/JP7672460B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3133030A1 (en) | 2020-09-17 |
| CN113557240A (zh) | 2021-10-26 |
| WO2020182860A1 (en) | 2020-09-17 |
| JP7672460B2 (ja) | 2025-05-07 |
| ES2953232T3 (es) | 2023-11-08 |
| EP3938378C0 (en) | 2023-08-02 |
| IL285914B1 (en) | 2024-07-01 |
| CN113557240B (zh) | 2025-02-25 |
| KR20220021451A (ko) | 2022-02-22 |
| EP3938378A1 (en) | 2022-01-19 |
| AU2020235344B2 (en) | 2024-10-24 |
| JP2024009801A (ja) | 2024-01-23 |
| IL285914B2 (en) | 2024-11-01 |
| JP2022522891A (ja) | 2022-04-20 |
| EP3938378B1 (en) | 2023-08-02 |
| JP7536031B2 (ja) | 2024-08-19 |
| US20220152186A1 (en) | 2022-05-19 |
| AU2020235344A1 (en) | 2021-09-23 |
| IL285914A (en) | 2021-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021011059A (es) | Particulas tipo norovirus con estabilidad mejorada. | |
| MX378238B (es) | Moléculas de unión con dominios de fibronectina de tipo iii modificadas con cisteína. | |
| EA201691589A1 (ru) | Стабилизированные основанные на фибронектине каркасные молекулы | |
| UA124343C2 (uk) | Капсиди аденоасоційованого вірусу і спосіб його використання | |
| MX2020010466A (es) | Vectores de virus que evitan anticuerpos. | |
| EA201890137A1 (ru) | Среда для культивирования клеток с добавлением таурина и способы применения | |
| EA201890315A1 (ru) | Молекулы антител, связывающие cd22 | |
| EP4659816A3 (en) | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY | |
| TR201909037T4 (tr) | Yeni protein deamidaz. | |
| MX2019001938A (es) | Metodos para detectar aav. | |
| MX2021007020A (es) | Dominios variables de inmunoglobulina mejorados. | |
| MX374811B (es) | Anticuerpos anti-tau y métodos de uso. | |
| EA201890321A1 (ru) | Молекулы антител, которые связываются с cd45 | |
| EA201691669A1 (ru) | Связывающие сывороточный альбумин домены фибронектина iii типа | |
| PH12016501937A1 (en) | Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage | |
| MX391476B (es) | Anticuerpos de alta afinidad y agregacion estable basados en dominios variables de vl y derivado de vhh. | |
| EA202190326A2 (ru) | Не содержащая сыворотки среда для культивирования клеток | |
| EA201890320A1 (ru) | Молекулы антител, которые связывают cd79 | |
| GB201915905D0 (en) | Viruses with modified capsid proteins | |
| ZA202306500B (en) | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins | |
| AR096236A1 (es) | Anticuerpos de dominio simple vhh dirigidos a norovirus gi.1 y gii.4 y sus usos | |
| EA201890914A1 (ru) | Доставка белка бактериями | |
| EA201390856A1 (ru) | Инактивация вирусов с применением улучшенного способа растворитель-детергент | |
| EA202191997A1 (ru) | Рекомбинантный рабдовирус, кодирующий ccl21 | |
| EA201492068A1 (ru) | Гидрохлоридная соль пептида и ее применение в комбинации с другими пептидами в иммунотерапии |